Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.13%114.8M | -8.85%123.6M | 6.13%128.1M | -0.78%509.2M | -0.73%135.6M | -11.87%117.3M | 15.50%135.6M | -4.28%120.7M | -20.22%513.2M | -9.30%136.6M |
| Operating revenue | -3.41%107.7M | -11.39%111.2M | 5.92%119.9M | -1.85%465.8M | -5.25%115.6M | -12.48%111.5M | 15.77%125.5M | -3.08%113.2M | -22.92%474.6M | -15.75%122M |
| Cost of revenue | 5.39%39.1M | 6.15%39.7M | -2.06%38.1M | 2.17%150.9M | -3.60%37.5M | -2.11%37.1M | 6.55%37.4M | 8.66%38.9M | -3.08%147.7M | 3.46%38.9M |
| Gross profit | -5.61%75.7M | -14.56%83.9M | 10.02%90M | -1.97%358.3M | 0.41%98.1M | -15.76%80.2M | 19.32%98.2M | -9.41%81.8M | -25.54%365.5M | -13.54%97.7M |
| Operating expense | -21.43%12.1M | -54.61%6.9M | -32.91%10.6M | 27.68%65.5M | 176.81%19.1M | -16.30%15.4M | 4.11%15.2M | 38.60%15.8M | -9.20%51.3M | -65.67%6.9M |
| Selling and administrative expenses | 7.08%12.1M | -35.56%5.8M | -45.45%8.4M | 4.44%47M | 85.25%11.3M | -24.67%11.3M | -30.77%9M | 41.28%15.4M | -7.79%45M | -62.80%6.1M |
| -General and administrative expense | 7.08%12.1M | -35.56%5.8M | -45.45%8.4M | 4.44%47M | 85.25%11.3M | -24.67%11.3M | -30.77%9M | 41.28%15.4M | -7.79%45M | -62.80%6.1M |
| Other operating expenses | ---- | -82.26%1.1M | 450.00%2.2M | 193.65%18.5M | 875.00%7.8M | 20.59%4.1M | 287.50%6.2M | -20.00%400K | -18.18%6.3M | -78.38%800K |
| Operating profit | -1.85%63.6M | -7.23%77M | 20.30%79.4M | -6.81%292.8M | -13.00%79M | -15.63%64.8M | 22.60%83M | -16.35%66M | -27.67%314.2M | -2.26%90.8M |
| Net non-operating interest income (expenses) | -29.63%-3.5M | 14.29%-3M | 21.62%-2.9M | 30.29%-12.2M | 41.03%-2.3M | 40.00%-2.7M | 23.91%-3.5M | 17.78%-3.7M | 5.91%-17.5M | 11.36%-3.9M |
| Non-operating interest expense | 29.63%3.5M | -14.29%3M | -21.62%2.9M | -30.29%12.2M | -41.03%2.3M | -40.00%2.7M | -23.91%3.5M | -17.78%3.7M | -5.91%17.5M | -11.36%3.9M |
| Other net income (expenses) | ||||||||||
| Income before tax | -3.22%60.1M | -6.92%74M | 22.79%76.5M | -5.43%280.6M | -11.74%76.7M | -14.11%62.1M | 25.99%79.5M | -16.26%62.3M | -28.64%296.7M | -1.81%86.9M |
| Income tax | -4.05%14.2M | -7.81%17.7M | 22.30%18.1M | -5.50%65.3M | -15.38%16.5M | -12.43%14.8M | 27.15%19.2M | -15.91%14.8M | -29.70%69.1M | -8.02%19.5M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2.96%45.9M | -6.63%56.3M | 22.95%58.4M | -5.40%215.3M | -10.68%60.2M | -14.62%47.3M | 25.63%60.3M | -16.37%47.5M | -28.31%227.6M | 0.15%67.4M |
| Net income continuous operations | -2.96%45.9M | -6.63%56.3M | 22.95%58.4M | -5.40%215.3M | -10.68%60.2M | -14.62%47.3M | 25.63%60.3M | -16.37%47.5M | -28.31%227.6M | 0.15%67.4M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -2.96%45.9M | -6.63%56.3M | 22.95%58.4M | -5.40%215.3M | -10.68%60.2M | -14.62%47.3M | 25.63%60.3M | -16.37%47.5M | -28.31%227.6M | 0.15%67.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2.96%45.9M | -6.63%56.3M | 22.95%58.4M | -5.40%215.3M | -10.68%60.2M | -14.62%47.3M | 25.63%60.3M | -16.37%47.5M | -28.31%227.6M | 0.15%67.4M |
| Diluted earnings per share | 0.00%0.2 | -4.00%0.24 | 25.00%0.25 | -5.26%0.9 | -10.71%0.25 | -13.04%0.2 | 25.00%0.25 | -16.67%0.2 | -28.57%0.95 | 0.00%0.28 |
| Basic earnings per share | 0.00%0.2 | -4.00%0.24 | 25.00%0.25 | -5.26%0.9 | -10.71%0.25 | -13.04%0.2 | 25.00%0.25 | -16.67%0.2 | -28.57%0.95 | 0.00%0.28 |
| Dividend per share | 4.00%0.26 | 4.00%0.26 | 4.00%0.26 | 4.17%1 | 4.17%0.25 | 4.17%0.25 | 4.17%0.25 | 4.17%0.25 | 60.00%0.96 | 0.00%0.24 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.